プレスリリース

Illumina to Webcast Live Presentation at the Goldman Sachs Global Healthcare Conference

SAN DIEGO--(BUSINESS WIRE)--May 30, 2017-- Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company’s presentation at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, California, on June 13, 2017. The live webcast is scheduled to begin at 2:40 PM PT and will feature a brief overview of the company by Francis deSouza, President and CEO, followed by a question and answer session.

The webcast can be accessed in the Investor Relations section of Illumina's web site under the "company" tab at www.illumina.com.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.

Source: Illumina, Inc.

Illumina, Inc.
Investors:
Rebecca Chambers, 858-255-5243
ir@illumina.com
or
Media:
Eric Endicott, 858-882-6822
pr@illumina.com

Recent Articles

大塚製薬株式会社が日本初の保険適用された造血器腫瘍遺伝子パネル検査を発売
大塚製薬株式会社が日本初の保険適用された造血器腫瘍遺伝子パネル検査を発売
研究により、未選択の脳性麻痺の相当な遺伝的起源が明らかになりました
研究により、未選択の脳性麻痺の相当な遺伝的起源が明らかになりました
イルミナのシンガポールチームががんと闘う
イルミナのシンガポールチームががんと闘う